Sulfonamide hypersensitivity syndrome
| Sulfonamide hypersensitivity syndrome | |
|---|---|
| Classification and external resources | |
| ICD-10 | Y40 |
| ICD-9-CM | E930.8 |
Sulfonamide hypersensitivity syndrome is similar to anticonvulsant hypersensitivity syndrome, but the onset is often sooner in the treatment course, generally after 7–14 days of therapy.[1]:118–9
It is considered immune-mediated.[2]
See also
References
- ↑ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0721629210.
- ↑ Cribb AE, Pohl LR, Spielberg SP, Leeder JS (August 1997). "Patients with delayed-onset sulfonamide hypersensitivity reactions have antibodies recognizing endoplasmic reticulum luminal proteins". J. Pharmacol. Exp. Ther. 282 (2): 1064–71. PMID 9262376.
This article is issued from Wikipedia - version of the 5/26/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.